Article
Los Angeles - The use of lipid-lowering drugs may inhibit the development of melanoma, according to results of two separate studies presented at the annual meeting of the Society for Investigative Dermatology.
Expanding Innovation and Education in Medical Aesthetics
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Teledermatology is Useful and Effective for Treating CSU Patients
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Impact of Malignant Melanoma on Employment and Work Ability
Clinical Pearls for Vitiligo and Pigmentation Complexities: Part 4